نتائج البحث

Non-surgical management of primary invasive melanoma

• Authors : Wang, Elizabeth A; Kao, Jason; Ma, Chelsea

Subjects: Biomedical and Clinical Sciences; Clinical Sciences; Oncology and Carcinogenesis

• Source: Journal of Dermatological Treatment. 32(6)

تفاصيل العنوان

Impact of a see-and-treat melanoma clinic on patient experience.

• Authors : Ip, Ken Hiu-Kan¹ (AUTHOR); Agnew, Karen¹ (AUTHOR); Cranshaw, Isaac² (AUTHOR)

• Source: Journal of Dermatological Treatment. Jun2022, Vol. 33 Issue 4, p2021-2023. 3p.

تفاصيل العنوان

Patients’ willingness to accept adverse event and cost tradeoffs from oral nicotinamide for reduced risk of non-melanoma skin cancer

• Authors : Marco Boeri; Maral K. Skelsey; James A. Schiro

Subjects: non-melanoma skin cancer; discrete choice; maximum acceptable risk

• Source: Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)

تفاصيل العنوان

Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implications.

• Authors : Mandel VD; Skin Cancer Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Meldola, Italy.; Dermatology Unit, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.

Subjects: Melanoma*/Melanoma*/Melanoma*/drug therapy ; Melanoma*/Melanoma*/Melanoma*/genetics ; Melanoma*/Melanoma*/Melanoma*/pathology

• Source: The Journal of dermatological treatment [J Dermatolog Treat] 2022 May; Vol. 33 (3), pp. 1368-1375. Date of Electronic Publication: 2020 Sep 09.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma.

• Authors : Cybulska-Stopa B; Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Cracow Branch, Poland.; Ziętek M

Subjects: Melanoma*/Melanoma*/Melanoma*/drug therapy ; Melanoma*/Melanoma*/Melanoma*/pathology ; Nivolumab*/Nivolumab*/Nivolumab*/adverse effects

• Source: The Journal of dermatological treatment [J Dermatolog Treat] 2022 Jun; Vol. 33 (4), pp. 2168-2174. Date of Electronic Publication: 2021 Jun 14.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

The reduction in the detection of melanoma during the coronavirus disease 2019 (COVID-19) pandemic in a melanoma center of South Italy.

• Authors : Villani A; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.; Fabbrocini G

Subjects: COVID-19* ; Melanoma*/Melanoma*/Melanoma*/diagnosis ; Melanoma*/Melanoma*/Melanoma*/epidemiology

• Source: The Journal of dermatological treatment [J Dermatolog Treat] 2022 May; Vol. 33 (3), pp. 1778. Date of Electronic Publication: 2020 Sep 09.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implications

• Authors : Victor Desmond Mandel; Matelda Medri; Ausilia Maria Manganoni

Subjects: melanoma; melanoma, cutaneous malignant; skin neoplasms

• Source: Journal of Dermatological Treatment, Vol 33, Iss 3, Pp 1368-1375 (2022)

تفاصيل العنوان

Artificial intelligence image recognition of melanoma and basal cell carcinoma in racially diverse populations.

• Authors : Aggarwal P; University of Cincinnati College of Medicine, Cincinnati, OH, USA.; Papay FA

Subjects: Carcinoma, Basal Cell*/Carcinoma, Basal Cell*/Carcinoma, Basal Cell*/diagnostic imaging ; Carcinoma, Basal Cell*/Carcinoma, Basal Cell*/Carcinoma, Basal Cell*/pathology ; Melanoma*/Melanoma*/Melanoma*/pathology

• Source: The Journal of dermatological treatment [J Dermatolog Treat] 2022 Jun; Vol. 33 (4), pp. 2257-2262. Date of Electronic Publication: 2021 Jun 30.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma.

• Authors : Arenbergerova M; Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.; Gkalpakiotis S

Subjects: COVID-19* ; Melanoma*/Melanoma*/Melanoma*/drug therapy ; Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/drug therapy

• Source: The Journal of dermatological treatment [J Dermatolog Treat] 2022 May; Vol. 33 (3), pp. 1782-1783. Date of Electronic Publication: 2020 Oct 22.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

A retrospective study comparing different injection approaches of 5-aminolevulinic acid in patients with non-melanoma skin cancer

• Authors : Weihong Zhao; Jun Wang; Ying Zhang

Subjects: 5-aminolevulinic acid; chinese dermal needle; needle-free injection

• Source: Journal of Dermatological Treatment, Vol 33, Iss 3, Pp 1465-1472 (2022)

تفاصيل العنوان